| Period Ending | Apr 29, 2013 | Jan 30, 2013 | Oct 30, 2012 | Jul 30, 2012 |
|---|
|
Total Revenue
|
441,674
|
784,514
|
582,112
|
410,071
| | Cost of Revenue | 367,726 | 679,985 | 488,053 | 339,707 | | |
Gross Profit
|
73,948
|
104,529
|
94,059
|
70,364
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
| 72,244 |
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
5,015
|
32,285
|
30,109
|
13,857
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 597 | 789 | 258 | 119 |
|
Earnings Before Interest And Taxes | 5,612 | 33,074 | 30,367 | 13,976 |
|
Interest Expense | 6,609 | 7,287 | 6,590 | 5,194 |
|
Income Before Tax | (997) | 25,787 | 23,777 | 8,782 |
|
Income Tax Expense | (394) | 10,351 | 9,418 | 3,477 |
|
Minority Interest | 189 | 170 | (298) | (96) |
|
|
|
Net Income From Continuing Ops | (414) | 15,606 | 14,061 | 5,209 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(414)
|
15,606
|
14,061
|
5,209
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(414)
|
15,606
|
14,061
|
5,209
|
|
0.17(0.88%) 11:09AM EDT - Nasdaq Real Time Price